IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 242 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $438,967 | -43.8% | 54,734 | +3.8% | 0.00% | -40.0% |
Q1 2024 | $781,740 | +54.2% | 52,749 | -15.4% | 0.01% | +25.0% |
Q4 2023 | $506,808 | +75.7% | 62,338 | -1.7% | 0.00% | +100.0% |
Q3 2023 | $288,415 | -22.9% | 63,388 | +19.4% | 0.00% | -33.3% |
Q2 2023 | $373,866 | +78.4% | 53,106 | +54.8% | 0.00% | +50.0% |
Q1 2023 | $209,579 | -1.8% | 34,301 | +2.7% | 0.00% | 0.0% |
Q4 2022 | $213,394 | -30.5% | 33,395 | +4.3% | 0.00% | -33.3% |
Q3 2022 | $307,000 | -13.0% | 32,033 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $353,000 | -37.5% | 31,945 | -5.9% | 0.00% | -40.0% |
Q1 2022 | $565,000 | -11.3% | 33,930 | +1.6% | 0.01% | 0.0% |
Q4 2021 | $637,000 | -22.4% | 33,381 | +0.2% | 0.01% | -28.6% |
Q3 2021 | $821,000 | -1.3% | 33,308 | +4.2% | 0.01% | 0.0% |
Q2 2021 | $832,000 | -17.9% | 31,962 | -0.2% | 0.01% | -22.2% |
Q1 2021 | $1,014,000 | -31.4% | 32,026 | +0.5% | 0.01% | -30.8% |
Q4 2020 | $1,478,000 | +38.3% | 31,852 | -1.9% | 0.01% | +18.2% |
Q3 2020 | $1,069,000 | +60.8% | 32,459 | +33.9% | 0.01% | +22.2% |
Q2 2020 | $665,000 | -11.8% | 24,241 | -3.7% | 0.01% | -30.8% |
Q1 2020 | $754,000 | – | 25,182 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |